This study quantified the risk of head and neck (HN) and esophageal cancers in 2770 Italian liver transplant (LT) recipients. A total of 186 post-transplant cancers were diagnosed-including 32 cases of HN cancers and nine cases of esophageal carcinoma. The 10-year cumulative risk for HN and esophageal carcinoma was 2.59%. Overall, HN cancers were nearly fivefold more frequent in LT recipients than expected (standardized incidence ratios - SIR=4.7, 95% CI: 3.2-6.6), while esophageal carcinoma was ninefold more frequent (SIR=9.1, 95% CI: 4.1-17.2). SIRs ranged from 11.8 in LT with alcoholic liver disease (ALD) to 1.8 for LT without ALD for HN cancers, and from 23.7 to 2.9, respectively, for esophageal carcinoma. Particularly elevated SIRs in LT with ALD were noted for carcinomas of tongue (23.0) or larynx (13.7). Our findings confirmed and quantified the large cancer excess risk in LT recipients with ALD. The risk magnitude and the prevalence of ALD herein documented stress the need of timely and specifically organized programs for the early diagnosis of cancer among LT recipients, particularly for high-risk recipients like those with ALD.

Piselli, P., Burra, P., Lauro, A., Baccarani, U., Ettorre, G., Vizzini, G., et al. (2015). Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010. TRANSPLANT INTERNATIONAL, 28(7), 841-848 [10.1111/tri.12555].

Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010

TISONE, GIUSEPPE;
2015-01-01

Abstract

This study quantified the risk of head and neck (HN) and esophageal cancers in 2770 Italian liver transplant (LT) recipients. A total of 186 post-transplant cancers were diagnosed-including 32 cases of HN cancers and nine cases of esophageal carcinoma. The 10-year cumulative risk for HN and esophageal carcinoma was 2.59%. Overall, HN cancers were nearly fivefold more frequent in LT recipients than expected (standardized incidence ratios - SIR=4.7, 95% CI: 3.2-6.6), while esophageal carcinoma was ninefold more frequent (SIR=9.1, 95% CI: 4.1-17.2). SIRs ranged from 11.8 in LT with alcoholic liver disease (ALD) to 1.8 for LT without ALD for HN cancers, and from 23.7 to 2.9, respectively, for esophageal carcinoma. Particularly elevated SIRs in LT with ALD were noted for carcinomas of tongue (23.0) or larynx (13.7). Our findings confirmed and quantified the large cancer excess risk in LT recipients with ALD. The risk magnitude and the prevalence of ALD herein documented stress the need of timely and specifically organized programs for the early diagnosis of cancer among LT recipients, particularly for high-risk recipients like those with ALD.
2015
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/06 - ONCOLOGIA MEDICA
English
aerodigestive cancers; cancer risk; immunosuppression; liver cirrhosis; liver diseases; oncogenic viruses; organ transplantation
Piselli, P., Burra, P., Lauro, A., Baccarani, U., Ettorre, G., Vizzini, G., et al. (2015). Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010. TRANSPLANT INTERNATIONAL, 28(7), 841-848 [10.1111/tri.12555].
Piselli, P; Burra, P; Lauro, A; Baccarani, U; Ettorre, G; Vizzini, G; Rendina, M; Rossi, M; Tisone, G; Zamboni, F; Bortoluzzi, I; Pinna, A; Risaliti, A; Galatioto, L; Vennarecci, G; Di Leo, A; Nudo, F; Sforza, D; Fantola, G; Cimaglia, C; Verdirosi, D; Virdone, S; Serraino, D
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/129614
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 13
social impact